SCHEMBL27384356

SCHEMBL27384356

CCc1cc2[nH]c(CNC(=O)N3CC(O)C3)cc2cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ RAB9A P51151 1/20 0.36
▸ DPP4 P27487 1/20 0.36
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35
▸ GRIN1 Q05586 1/20 0.35
▸ GRIN2A Q12879 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ GRIN2C Q14957 1/20 0.35
▸ GRIN3A Q8TCU5 1/20 0.35
▸ EPHX2 P34913 13/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CYP2C9 P11712 3/20 0.34
▸ CYP2J2 P51589 3/20 0.34
▸ HTT P42858 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384652 0.86 SMN1; SMN2 (0.41) SMN1; SMN2RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL27384661 0.85 EPHX2 (0.39) SMN1; SMN2RAB9AGRIN2BEPHX2CYP2C9
SCHEMBL27384658 0.83 HTT (0.46) SMN1; SMN2EPHX2MEN1MAPTKMT2A
SCHEMBL27382489 0.80 SMN1; SMN2 (0.47) SMN1; SMN2RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL27383947 0.79 RAB9A (0.55) SMN1; SMN2RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL27382554 0.78 MTNR1A (0.46) SMN1; SMN2RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL27383138 0.77 SMN1; SMN2 (0.45) SMN1; SMN2RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL27382911 0.77 RAB9A (0.42) SMN1; SMN2RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL27383268 0.77 RAB9A (0.61) SMN1; SMN2RAB9AMEN1KMT2AHTT
SCHEMBL31408537 0.76 SMN1; SMN2 (0.36) SMN1; SMN2MEN1LMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback